Top Markets
Coin of the day
Yew Bio-Pharm Group, Inc. Yew Bio-Pharm Group, Inc.

Yew Bio-Pharm Group, Inc.

YEWB
株式のランク #41774
Yew Bio-Pharm Group, Inc. (YEWB) operates as a cultivator and purveyor of yew... Yew Bio-Pharm Group, Inc. (YEWB) operates as a cultivator and purveyor of yew trees across both the People's Republic of China and the United States, utilizing its subsidiaries. A significant portion of its operations involves supplying raw yew materials, specifically branches and leaves, for the production of Traditional Chinese Medicine (TCM), particularly those containing the compound taxol. The company also processes and distributes these vital yew components for TCM applications. Beyond medicinal applications, Yew Bio-Pharm cultivates and markets various forms of yew trees, from young seedlings and mature specimens to ornamental potted miniatures. It also leverages yew tree timber for the creation and sale of furniture and handcrafted items. Its diverse product portfolio further includes a range of agricultural goods such as yew-based candles, pine needle extracts, taxus cuspidate extracts, northeast yew extracts, and yew essential oil soaps. Additionally, it sells wood ear mushrooms. The group also extends its reach into the cosmetics market, engaging in their marketing and distribution. Established in 2007, the company maintains its headquarters in El Monte, California.
株価
$0.0002
最終同期: 2023-11-09
時価総額
$10.40K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Yew Bio-Pharm Group, Inc. (YEWB)

カテゴリー

Yew Bio-Pharm Group, Inc.(YEWB)の収益
Aug 2026 時点の収益 TTM: 0
Yew Bio-Pharm Group, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Yew Bio-Pharm Group, Inc. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益